Peri-Implantitis Treatment Market size was valued at USD 2.16 Billion in 2023 and is likely to exceed USD 5.72 Billion by the end of 2036, registering over 7.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of peri-implantitis treatment is evaluated at USD 2.31 Billion. The growth of the market can be attributed to the growing demand for dental implants since these implants are observed to cause peri-implantitis if they get loose. Additionally, the growing prevalence of oral diseases is also estimated to encourage market growth during the forecast period. According to data from the World Health Organization (WHO), nearly 3.5 billion people are affected by oral diseases across the globe. Moreover, almost 10% of the global population is affected with severe periodontal (gum) disease, which may result in tooth loss.
Furthermore, global peri-implantitis treatment market trends such as poor design of dental implants due to a lack of awareness and technology, excessive mechanical stress, and metal corrosion causing peri-implantitis are expected to have an impact on market growth over the forecast period. Poor design of implants placed in the mouth can be uncomfortable and delivers severe wounds at gum linings or the interior of gums. The growth of the market can be attributed to the growing demand for dental implants, along with the adoption of advanced technology in the oral healthcare sector. The prevalence of oral disease is so high that more than 32 million school hours are lost owing to emergency dental care. Therefore, all these factors are anticipated to boost the growth of the market over the forecast period.
Growth Drivers
Growing Consumption of Cigarette – cigarette is the most dangerous substance when it comes to oral health. Various studies across the world have shown that smokers who had dental implants were most likely to get peri-implantitis. Smoking habits can harm surgically placed implants. For instance, it was estimated that more than 38 million adults in the United States smoke cigarettes while around 7 million people lost their lives owing to tobacco consumption in 2020.
Rising Geriatric Population – Elderly population is more prone to peri-implantitis since it has been observed that people aged 65 and above are independently associated with peri-implantitis. Based on the data released by the World Health Organization (WHO) 1 out of 6 people is expected to be aged 60 and above by 2030.
Increasing Awareness of Oral Care – oral health is the most necessary step to avoid since it can be caused by several oral diseases. As of 2022, more than 3 billion people were projected to live with oral diseases across the globe. Meanwhile, every 1 in 4 adults in the USA is projected to have untreated cavities.
Growing Incidences of Periodontal Disease – the higher prevalence of periodontal disease across the globe is also anticipated to hike the market growth over the forecast period. For instance, the prevalence of periodontal disease is so high that it was anticipated that more than 85% of people are projected to experience periodontal disease once in a lifetime across the globe.
Challenges
The diagnosis of peri-implantitis is quite difficult since, for several years, it grows in the gums silently. It becomes difficult to distinguish the reason for bone decaying if it is due to bone remodeling and or infection. Most people are not even aware of the treatment. Therefore, this factor is estimated to hamper the growth of the market over the forecast period.
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
8% |
|
Base Year Market Size (2023) |
USD 2 Billion |
|
Forecast Year Market Size (2036) |
USD 5 Billion |
|
Regional Scope |
|
Type {Surgical (Bone Regeneration, Open Flap Debridement, Implantoplasty)
The global peri-implantitis treatment market is segmented and analyzed for demand and supply by type into surgical, non-surgical, and surface decontamination. Out of the three types, the surgical segment is estimated to gain the largest market share in the year 2036. The growth of the segment can be attributed to the fact that surgeries offer immediate relief and a higher success rate of permanent cures. Moreover, surgery is a quicker treatment process, whereas antibiotics and other non-surgical methods take a significant amount of time. This is why, people prefer surgical treatment, which is estimated to boost segment growth over the forecast period. In the surgical phase of treatment, oral healthcare providers use respective regenerative techniques along with the two main approaches that are augmentative therapy and non-augmentative therapy. Hence, the growing number of dental implants causing peri-implantitis is also escalating the number of surgeries over the forecast period. For instance, in the United States, more than 3 million people are noticed to have implants.
End-user (Dental Clinics, Hospitals, Pharmacies)
The global peri-implantitis treatment market is also segmented and analyzed for demand and supply by end-user into dental clinics, hospitals, pharmacies, and others. Amongst these segments, the dental clinics segment is expected to garner a significant share in the year 2036. Patients suffering from peri-implantitis are recommended to visit dental clinics. Oral diseases spurring across the globe owing to alcohol and tobacco consumption, and poor hygiene where the high possibility to get cavities, oral cancer, and periodontal diseases is rising. Hence, dental clinics are observed to have huge patient pools owing to escalating awareness of the global population towards oral health monitors. Additionally, the surge in people getting dental implants is further anticipated to hike the segment growth over the forecast period. For instance, it was estimated that approximately 500,000 implants are placed every year in the United States. Therefore, all these factors are expected to hike the segment growth during the forecast period.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By End-User |
|
APAC Market Statistics
The Asia Pacific peri-implantitis treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market can be attributed majorly to the increasing prevalence of oral diseases, along with rising awareness regarding oral health. In several Asian countries, people do not give the necessary attention to their oral health and prefer traditional methods to cure the oral disease which results in a high number of people suffering from these diseases and the need for proper treatment. For instance, in the South Asia region, more than 875 million untreated dental caries cases were diagnosed in 2019. Hence, higher demand for oral care products appears in the Asia Pacific region where the regional oral care segment is estimated to reach approximately USD 20 billion by 2027. Hence, such factors are anticipated to expand the market size over the forecast period.
North American Market Forecast
The North America peri-implantitis treatment market, amongst the market in all the other regions, is projected to hold the second largest share during the forecast period. The growth of the market can be attributed majorly to growing incidences of oral diseases in the region backed by the higher consumption of tobacco and alcohol. In this region, people are observed to consume alcohol and tobacco from an early age which results in damage to their teeth. As per the data by the Centers for Disease Control and Prevention (CDC), 46% of all adults, aged 30 years or older, suffer from some kind of gum disease while 9% of adults are affected by severe gum diseases. Furthermore, the growing geriatric population with a higher need for dental implants and treatment for better oral health is also anticipated to boost the market growth over the forecast period.
Neoss Limited announced the acquisition of Legend Life Tech, to establish Neoss China, a regional subsidiary of the global implant manufacturing company. Neoss Limited aims to expand its global presence in the Asia Pacific region.
Geistlich Pharma AG. acquired Meta Technologies S.r.l., along with the employees working for the company. Geistlich Pharma expanded its existing offering of oral regeneration specialists, with the acquisition of Meta Technologies S.r.l.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?